Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis

Abstract In the present study, we demonstrated the emergence of dalbavancin non-susceptible and teicoplanin-resistant Staphylococcus aureus small colony variants which were selected in vivo through long-term treatment with dalbavancin. A 36-year-old man presented with a cardiac device-related S. aur...

Full description

Bibliographic Details
Main Authors: Manuel Kussmann, Matthias Karer, Markus Obermueller, Katy Schmidt, Wolfgang Barousch, Doris Moser, Marion Nehr, Michael Ramharter, Wolfgang Poeppl, Athanasios Makristathis, Stefan Winkler, Florian Thalhammer, Heinz Burgmann, Heimo Lagler
Format: Article
Language:English
Published: Taylor & Francis Group 2018-12-01
Series:Emerging Microbes and Infections
Online Access:http://link.springer.com/article/10.1038/s41426-018-0205-z

Internet

http://link.springer.com/article/10.1038/s41426-018-0205-z

Similar Items